Literature DB >> 31489800

Analysis of cardiovascular disease-related NF-κB-regulated genes and microRNAs in TNFα-treated primary mouse vascular endothelial cells.

Hui Zhu1, Yun Li1, Mao-Xian Wang1, Ju-Hong Wang1, Wen-Xin Du2, Fei Zhou1.   

Abstract

Activated nuclear factor-κB (NF-κB) plays an important role in the development of cardiovascular disease (CVD) through its regulated genes and microRNAs (miRNAs). However, the gene regulation profile remains unclear. In this study, primary mouse vascular endothelial cells (pMVECs) were employed to detect CVD-related NF-κB-regulated genes and miRNAs. Genechip assay identified 77 NF-κB-regulated genes, including 45 upregulated and 32 downregulated genes, in tumor necrosis factor α (TNFα)-treated pMVECs. Ten of these genes were also found to be regulated by NF-κB in TNFα-treated HeLa cells. Quantitative real-time PCR (qRT-PCR) assay confirmed the up-regulation of Egr1, Tnf, and Btg2 by NF-κB in the TNFα-treated pMVECs. The functional annotation revealed that many NF-κB-regulated genes identified in pMVECs were clustered into classical NF-κB-involved biological processes. Genechip assay also identified 26 NF-κB-regulated miRNAs, of which 21 were upregulated and 5 downregulated, in the TNFα-treated pMVECs. Further analysis showed that nine of the identified genes are regulated by seven of these miRNAs. Finally, among the identified NF-κB-regulated genes and miRNAs, 5 genes and 12 miRNAs were associated with CVD by miRWalk and genetic association database analysis. Taken together, these findings show an intricate gene regulation network raised by NF-κB in TNFα-treated pMVECs. The network provides new insights for understanding the molecular mechanism underlying the progression of CVD.

Entities:  

Keywords:  Cardiovascular disease; Nuclear factor-κB (NF-κB); MicroRNA; Endothelial cell

Mesh:

Substances:

Year:  2019        PMID: 31489800      PMCID: PMC6751486          DOI: 10.1631/jzus.B1800631

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  47 in total

Review 1.  The clinical implications of endothelial dysfunction.

Authors:  Michael E Widlansky; Noyan Gokce; John F Keaney; Joseph A Vita
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

2.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

3.  The genetic association database.

Authors:  Kevin G Becker; Kathleen C Barnes; Tiffani J Bright; S Alex Wang
Journal:  Nat Genet       Date:  2004-05       Impact factor: 38.330

Review 4.  Endothelial function: cardiac events.

Authors:  Amir Lerman; Andreas M Zeiher
Journal:  Circulation       Date:  2005-01-25       Impact factor: 29.690

5.  Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment.

Authors:  Yaw-Chyn Lim; Guillermo Garcia-Cardena; Jennifer R Allport; Mandy Zervoglos; Andrew J Connolly; Michael A Gimbrone; Francis W Luscinskas
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 6.  Secondary endothelial dysfunction: hypertension and heart failure.

Authors:  C M Boulanger
Journal:  J Mol Cell Cardiol       Date:  1999-01       Impact factor: 5.000

Review 7.  Oxidative stress and vascular disease.

Authors:  Nageswara R Madamanchi; Aleksandr Vendrov; Marschall S Runge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-11-11       Impact factor: 8.311

8.  NF-kappaB binds to a polymorphic repressor element in the MMP-3 promoter.

Authors:  Ruth C Borghaei; P Lyle Rawlings; Masoud Javadi; Joanna Woloshin
Journal:  Biochem Biophys Res Commun       Date:  2004-03-26       Impact factor: 3.575

9.  Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1).

Authors:  M F Iademarco; J J McQuillan; G D Rosen; D C Dean
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

10.  Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes.

Authors:  Claire L Varley; Suzanne Armitage; Gholamhossein Hassanshahiraviz; Alan J Dickson
Journal:  Cytokine       Date:  2003-08-07       Impact factor: 3.861

View more
  4 in total

1.  Puerarin Attenuates LPS-Induced Inflammatory Responses and Oxidative Stress Injury in Human Umbilical Vein Endothelial Cells through Mitochondrial Quality Control.

Authors:  Xing Chang; Tian Zhang; Dong Liu; Qingyan Meng; Peizheng Yan; Duosheng Luo; Xue Wang; XiuTeng Zhou
Journal:  Oxid Med Cell Longev       Date:  2021-02-27       Impact factor: 6.543

2.  Identification of PTPRR and JAG1 as key genes in castration-resistant prostate cancer by integrated bioinformatics methods.

Authors:  Ji-Li Wang; Yan Wang; Guo-Ping Ren
Journal:  J Zhejiang Univ Sci B       Date:  2020 Mar.       Impact factor: 3.066

3.  MicroRNA-133a-Dependent Inhibition of Proximal Tubule Angiotensinogen by Renal TNF (Tumor Necrosis Factor).

Authors:  Shoujin Hao; Joseph Salzo; Hong Zhao; Mary Hao; Zbigniew Darzynkiewicz; Nicholas R Ferreri
Journal:  Hypertension       Date:  2020-11-02       Impact factor: 10.190

Review 4.  The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans.

Authors:  Jessica Maiuolo; Cristina Carresi; Micaela Gliozzi; Rocco Mollace; Federica Scarano; Miriam Scicchitano; Roberta Macrì; Saverio Nucera; Francesca Bosco; Francesca Oppedisano; Stefano Ruga; Anna Rita Coppoletta; Lorenza Guarnieri; Antonio Cardamone; Irene Bava; Vincenzo Musolino; Sara Paone; Ernesto Palma; Vincenzo Mollace
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.